Post My Press Release

Free Press Release Distribution

Category: Life Sciences (Page 1 of 36)

Nasal Drug Delivery Systems Market

Nasal Drug Delivery Systems Market 2019 Segmentation and Analysis by Recent Trends, Development and Growth

Nasal Drug Delivery Systems market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.

This report focuses on Nasal Drug Delivery Systems volume and value at global level, regional level and company level. From a global perspective, this report represents overall Nasal Drug Delivery Systems market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.

At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:

  • Merck
  • GSK
  • AstraZeneca
  • Johnson & Johnson
  • BD
  • Pfizer
  • Baxter International
  • Valeant Pharmaceuticals International
  • Novartis

Report Sample includes:
– Table of Contents
– List of Tables & Figures
– Charts
– Research Methodology

Get FREE Sample of this Report at https://www.24marketreports.com/report-sample/global-nasal-drug-delivery-systems-2019-770

Nasal Drug Delivery Systems Market

Segment by Regions

  • North America
  • Europe
  • China
  • Japan

Segment by Type

  • Nasal Spray
  • Nasal Powders
  • Nasal Drops
  • Nasal Gels
  • Others

Segment by Application

  • Hospitals Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Get the Complete Report & TOC at https://www.24marketreports.com/life-sciences/global-nasal-drug-delivery-systems-2019-770

CONTACT US:

276 5th Avenue, New York , NY 10001,United States
International: (+1) 646 781 7170
Email: help@24marketreports.com

Follow Us On linkedin :- https://www.linkedin.com/company/24-market-reports

Market Trends for Digestive Remedies in China, Forecast – 2023

Market Reports on China Provides the Trending Market Research Report on “Digestive Remedies in China” under Remedies/Therapies Category. The report offers a collection of superior market research, market analysis, competitive intelligence and Market reports.

The growing number of Chinese consumers affected by digestive diseases and disorders is fuelling the demand for and sales of digestive remedies. Moving forward, awareness of a better work-life balance and self-healthcare

Request a free sample copy of Digestive Remedies Market Report @
http://www.marketreportsonchina.com/marketreports/Sample/Reports/225391

Busy lifestyles lead many working people to eat out or eat at their desk during their lunch break. They opt for easy to prepare food or grab-and-go food, which typically pose a higher risk of digestive problems. In addition, mounting stress can cause digestive disorders. In turn, the growing number of Chinese consumers affected by digestive diseases and disorders is fuelling the demand for and sales of digestive remedies. Moving forward, awareness of a better work-life balance and self-healthcar…

Digestive Remedies in China report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.

Product coverage: Diarrhoeal Remedies, IBS Treatments, Indigestion and Heartburn Remedies, Laxatives, Motion Sickness Remedies, Paediatric Digestive Remedies.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Digestive Remedies market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Browse our full report with Table of Contents:
http://www.marketreportsonchina.com/marketreports/digestive-remedies-in-china/225391

About Market Reports on China:Market Reports on China is thus the one-stop solution for the entire market research requirements with regards to China.
We provide you with insight and analysis on the country’s economic outlook at the national, regional and city level, presenting deep understanding of disparities and evolutionary paths. Get a complete, consistent and concise view of your markets with comprehensive industry reports. Our latest regional databanks, forecasts, and detailed risk ratings will help you to identify risk and opportunities in every industry and develop strategic plans to deal with the competitiveness in the Chinese market.

Contact us:
Market Reports on China
Tel: +91 22 27810772 / 27810773
Email: info@marketreportsonchina.com
Website: http://www.marketreportsonchina.com

Endocrine System Drug Market Trends in China, 2018 (Analysis and Forecasts: 2023)

Market Reports on China Provides the Trending Market Research Report on “China Endocrine System Drug Market Report 2018” under DrugsCategory. The report offers a collection of superior market research, market analysis, competitive intelligence and Market reports.

Geographically, this report split China into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Endocrine System Drug for these regions, from 2012 to 2023 (forecast).

Request a free sample copy ofEndocrine System DrugMarket Report @
http://www.marketreportsonchina.com/marketreports/Sample/Reports/1374051

Geographically, this report split China into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Endocrine System Drug for these regions, from 2012 to 2023 (forecast), including
South China
East China
Southwest China
Northeast China
North China
Central China
Northwest China

China Endocrine System Drug market competition by top manufacturers/players, with Endocrine System Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Novo Nordisk
Sanofi
Merck
Eli Lilly
AstraZeneca
AbbVie

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
Diabetes Drug
Human Growth Hormones
Thyroid Hormone Disorder Drugs
Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Endocrine System Drug for each application, including
Hospital
Clinic
Medical Center
Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Browse our full report with Table of Contents:
http://www.marketreportsonchina.com/marketreports/china-endocrine-system-drug-market-report-2018/1374051

About Market Reports on China:
Market Reports on China is thus the one-stop solution for the entire market research requirements with regards to China.
We provide you with insight and analysis on the country’s economic outlook at the national, regional and city level, presenting deep understanding of disparities and evolutionary paths. Get a complete, consistent and concise view of your markets with comprehensive industry reports. Our latest regional databanks, forecasts, and detailed risk ratings will help you to identify risk and opportunities in every industry and develop strategic plans to deal with the competitiveness in the Chinese market.

Contact us:
Market Reports on China
Tel: +91 22 27810772 / 27810773
Email: info@marketreportsonchina.com
Website: http://www.marketreportsonchina.com

Key Factors For Shaping The China Market Trend For Herbal Supplements & Remedies

Market Reports on China Provides the Trending Market Research Report on “China HerbalSupplements and Remedies Market Report 2018” under Remedies/TherapiesCategory. The report offers a collection of superior market research, market analysis, competitive intelligence and Market reports.

Geographically, this report split China into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Herbal Supplements and Remedies for these regions, from 2012 to 2023 (forecast).

Request a free sample copy of Herbal Supplements & Remedies Market Report @
http://www.marketreportsonchina.com/marketreports/Sample/Reports/1195836

Geographically, this report split China into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Herbal Supplements and Remedies for these regions, from 2012 to 2023 (forecast), including
South China
East China
Southwest China
Northeast China
North China
Central China
Northwest China

China Herbal Supplements and Remedies market competition by top manufacturers/players, with Herbal Supplements and Remedies sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
NBTY(US)
Tsumura(JP)
Weleda(CH)
DSM(NL)
Nature’s Sunshine Products(US)
Madaus(DE)
Nutraceutical(US)
Arkopharma(FR)
Schwabe(DE)
Ricola(CH)
Blackmores(AU)
Dabur(IN)
Herbal Africa(ZA)
Pharma Nord APS(DM)
SIDO MUNCUL(ID)

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
Mono-Herb Type
Multi-Herb Type

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Herbal Supplements and Remedies for each application, including
Pharmaceutical Industry
Health Care Industry
Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Browse our full report with Table of Contents:
http://www.marketreportsonchina.com/marketreports/china-herbal-supplements-and-remedies-market-report-2018/1195836

About Market Reports on China:
Market Reports on China is thus the one-stop solution for the entire market research requirements with regards to China.
We provide you with insight and analysis on the country’s economic outlook at the national, regional and city level, presenting deep understanding of disparities and evolutionary paths. Get a complete, consistent and concise view of your markets with comprehensive industry reports. Our latest regional databanks, forecasts, and detailed risk ratings will help you to identify risk and opportunities in every industry and develop strategic plans to deal with the competitiveness in the Chinese market.

Contact us:
Market Reports on China
Tel: +91 22 27810772 / 27810773
Email: info@marketreportsonchina.com
Website: http://www.marketreportsonchina.com

Global Radiotherapy Market Revenue, Opportunity, Segment and Key Trends 2018-2025

Bharat Book Bureau Provides the Trending Market Research Report on “Global Radiotherapy Market Size Study, By Type, Application, End-User And Regional Forecasts 2018-2025” under Life Sciences category. The report offers a collection of superior market research, market analysis, competitive intelligence and industry reports.

Global Radiotherapy Market Size Study, By Type (External Beam Radiation Therapy, Internal Radiation Therapy And Systemic Radiation Therapy), Application (Skin & Lip Cancer, Breast Cancer, Head & Neck Cancer, Prostate Cancer, Cervical Cancer, Spine Cancer, Lung Cancer And Others) End-User (Hospitals, Cancer Research Institutes And Ambulatory & Radiotherapy Centers) And Regional Forecasts 2018-2025

Global Radiotherapy Market to reach USD 12.3 billion by 2025.

Global Radiotherapy Market is valued at approximately USD 7.2 billion in 2017 and is anticipated to grow with a healthy growth rate of more than 6.90 % over the forecast period 2018-2025. Technological advancements in radiotherapy and increasing government investments to meet the demand for cancer treatment are some key trend triggering the growth of the radiotherapy market over the forecast period.

Request a free sample copy of Radiotherapy Market Report @ https://www.bharatbook.com/marketreports/Sample/Reports/1374951

Key driving factor for the radiotherapy market is increasing prevalence of cancer. Since, radiotherapy tests allows clinicians to identify and detect organism accurately and helps to offer proper guidance to clinicians thereby, promoting the demand for radiotherapy tests over the forecast period. According to Cancer index, it was estimated that around 2,814,000 of Chinese would die from cancer in 2015 equivalent to around 7,500 cancer deaths every day on an average basis in the country. Similarly, as per the National Institute of Cancer Prevention and Research of India, 1 woman affected by cervical cancer dies due to its impact in every 8 minutes. For every 2 women newly diagnosed with breast cancer, 1women die. Every year, over 7 lakh cancer cases are registered in India which in turn causes 5,56,400 deaths in year that is fueling the adoption and utility of radiotherapy in India. Also, as per the National Cancer Control Strategy (2017-2022), Cancer is estimated to be the 3rd leading cause of death after cardiovascular diseases and infectious diseases in Middle East & Africa region. Thus, high prevalence of cancer would increase the need for radiotherapy treatment as it is beneficial to treat cancer, promoting the growth of the radiotherapy market. Furthermore, growing awareness about the advantages of radiotherapy along with the use of particle therapy for cancer treatment offers lucrative growth prospects for the Radiotherapy market. However, lack of trained personnel expected to hinder the growth of the market during the forecast period.

On the basis of segmentation, the radiotherapy market is segmented into type, application and end-user. Type segment of global radiotherapy market is classified into external beam radiation therapy, internal radiation therapy and systemic radiation therapy of which external beam radiotherapy segment is expected to grow at a highest CAGR owing to the increases accuracy and precision of tumor targeting. On the basis of application segment, the market is diversified into skin & lip cancer, breast cancer, head & neck cancer, prostate cancer, cervical cancer, spine cancer, lung cancer and others. The end-user segment is classified into hospitals, cancer research institutes and ambulatory & radiotherapy centers of which hospital segment is anticipated to witness lucrative growth owing to the increasing installation of advanced radiotherapy equipment along with government initiatives and funding to promote the adoption of advanced cancer treatment technologies.

The regional analysis of radiotherapy market is considered for the key regions such as North America, Europe, Asia Pacific, Latin America and ROW. North America holds the leading position in radiotherapy market owing to the increasing number of cancer cases coupled with the technological advancements in radiotherapy equipment. Also, the dominance of North America region is witnessed owing to the presence of market players such as GE Healthcare, Varian Medical Systems, Inc and others. Whereas, Asia-Pacific is expected to emerge as the fastest growing region in terms of market share. The growth of Asia-Pacific region is witnessed owing to high prevalence of cancer along with rising geriatric population. Also, improving healthcare infrastructure and services in rural areas is also expected to supplement the growth of Asia-Pacific region over the forecast period.

The leading market players include-

-GE Healthcare

-Siemens AG

-Canon Medical Systems Corporation

-Varian Medical Systems, Inc.

-Ion Beam Applications

-Nordion

-Isoray

-Mirada Medical

-Elekta AB

-Varian Medical Systems Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type

-External Beam Radiation Therapy

-Internal Radiation Therapy

-Systemic Radiation Therapy

By Application:

-Skin & Lip Cancer

-Breast Cancer

-Head & Neck Cancer

-Prostate Cancer

-Cervical Cancer

-Spine Cancer

-Lung Cancer

-Others

By End-user:

-Hospitals

-Cancer Research Institutes

-Ambulatory & Radiotherapy Centers

By Regions:

-North America

U.S.

Canada

-Europe

UK

Germany

ROE

-Asia Pacific

China

India

Japan

ROAPEC

-LAMEA

Brazil

Mexico

-ROW

Middle East & Africa

Browse our full report with Table of Contents :https://www.bharatbook.com/marketreports/global-radiotherapy-market-size-study-by-type-application-end-user-and-regional-forecasts-2018-2025/1374951

About Bharat Book Bureau:

Bharat Book is Your One-Stop-Shop with an exhaustive coverage of 4,80,000 reports and insights that includes latest Market Study, Industry Trends & Analysis, Forecasts & Customized Intelligence, Newsletters and Online Databases. Overall a comprehensive coverage of major industries with a further segmentation of 100+ subsectors.

Contact us at:

Bharat Book Bureau

Tel: +91 22 27810772 / 27810773

Email: poonam@bharatbook.com

Website: www.bharatbook.com

Follow us on : Twitter, Facebook, LinkedIn, Google Plus



Global Homeopathic Medicine Market : Size, Outlook, Trend and Forecast 2018-2025

Bharat Book Bureau Provides the Trending Market Research Report on “Global Homeopathic Medicine Market Size study, by Type (Plant Based, Animal Based, Minerals Based), By Application (Hospitals, Homeopathic Clinics) and Regional Forecasts 2018-2025” under Life Sciences category. The report offers a collection of superior market research, market analysis, competitive intelligence and industry reports.

Global Homeopathic Medicine Market to reach USD XX billion by 2025.

Global Homeopathic Medicine Market valued approximately USD XX billion in 2017 is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2018-2025. The Homeopathic Medicine Market is continuously growing across the world over the coming years.

Homeopathy is a field of alternative medicine, which works on the principle of similarity of symptoms i.e. a substance causing symptoms of disease in healthy individual will show same symptoms in the sick. Homeopathic medicine include treatment using natural sources such as plants, animals and chemicals or minerals. It involves administration of small doses having specific composition. Increasing cases of disorders associated with lifestyle and rising awareness regarding homeopathic medicine are the substantial driving factors of the market across the globe. In addition, increasing demand of homeopathic medicines from developing economies is the major factor which creating numerous opportunity in the market over the coming years. Homeopathic medicines is safe to use, it is effective & fast acting response, it is obtained from natural sources, it enhances resistant to diseases and many more. These benefits are also propelling the demand of Homeopathic medicines among its end-users across the world. However, lack of awareness in some of the countries and strict regulatory requirements governing the use of homeopathy are the factors which limiting the market growth of Homeopathic Medicine over the coming years.

Request a free sample copy of Homeopathic Medicine Market Report @ https://www.bharatbook.com/marketreports/Sample/Reports/1367574

The regional analysis of Global Homeopathic Medicine Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/dominant region in the global Homeopathic Medicine market due to increasing awareness associated with Homeopathic medicine and treatment in the region. Europe is the second largest region to grow in the Homeopathic Medicine market due to rising number of homeopathic practitioners and increasing use of homeopathic medicine by the European people in the region. Asia-Pacific is also expected to grow at higher growth / higher CAGR over the forecast period 2018-2025.

The major market player included in this report are:

• Hahnemann Laboratories Inc.

• Natural Health Supply

• Boiron USA

• Homelab USA

• SBL

• Hyland’s Homeopathic

• Nelson & Co. Ltd.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

-Plant Based

-Animal Based

-Minerals Based

By Application:

-Hospitals

-Homeopathic Clinics

By Regions:

-North America

U.S.

Canada

-Europe

UK

Germany

-Asia Pacific

China

India

Japan

-Latin America

Brazil

Mexico

-Rest of the World

Browse our full report with Table of Contents :https://www.bharatbook.com/marketreports/global-homeopathic-medicine-market-size-study-by-type-plant-based-animal-based-minerals-based-by-application-hospitals-h/1367574

About Bharat Book Bureau:

Bharat Book is Your One-Stop-Shop with an exhaustive coverage of 4,80,000 reports and insights that includes latest Market Study, Industry Trends & Analysis, Forecasts & Customized Intelligence, Newsletters and Online Databases. Overall a comprehensive coverage of major industries with a further segmentation of 100+ subsectors.

Contact us at:

Bharat Book Bureau

Tel: +91 22 27810772 / 27810773

Email: poonam@bharatbook.com

Website: www.bharatbook.com

Follow us on : Twitter, Facebook, LinkedIn, Google Plus



China IVD Market Trends and Forecast – 2025

Market Reports on China Provides the Trending Market Research Report on “China IVD Market, Share, Trends, Regulations, Reimbursement & Key Players Analysis – Forecast to 2025” under HealthcareCategory. The report offers a collection of superior market research, market analysis, competitive intelligence and Market reports.

China represents one of the largest clinical laboratory markets in the Asia-Pacific region, and the fastest growing among the top ten IVD country markets. China’s quickly aging population means the country is experiencing an explosion of chronic conditions such as diabetes, heart disease and cancer.

Request a free sample copy of In-Vitro Diagnostics (IVD) Market Report @
http://www.marketreportsonchina.com/marketreports/Sample/Reports/1121532

China In-Vitro Diagnostics (IVD) market is likely to exceed US$ 15 Billion mark by 2025. China is a large and fast-growing in vitro diagnostics (IVD) market – in fact, only second to the United States in terms of value. Historically, large multinational companies have dominated IVD market in China; today, domestic companies such as Shanghai Kehua Bio-Engineering (KHB) being one of the largest – are now gaining market share.

China represents one of the largest clinical laboratory markets in the Asia-Pacific region, and the fastest growing among the top ten IVD country markets. China’s quickly aging population means the country is experiencing an explosion of chronic conditions such as diabetes, heart disease and cancer. All of these conditions can be diagnosed and monitored using IVD products. Further, the average Chinese consumer is now willing and able to pay more for healthcare than a decade years ago. Hence, China has the potential for more dramatic growth in the future.

China IVD Market Segment Wise Analysis

Immunoassay captures maximum share of the China IVD market.

Clinical Chemistry holds the 2nd position in China IVD market being followed by Molecular Testing.

The molecular testing market in China is expected to show double digits growth rate during the forecasted period.

China SMBG market is dominated by foreign IVD companies such as Roche.

Microbiology and Hematology segments are competing closely with each other to grab maximum share of the pie.

Point of Care Testing accounts for least share of the China IVD market.

China IVD Market Company Analysis

Roche captures maximum share of the China IVD market.

Sysmex Corporation and Mindary Medical are other top two players in the China IVD market.

Sysmex is expanding its business portfolio in China, such as by entering the immunochemistry field there in 2015.

At present, many local players are present in China IVD market and their combined market share is likely to exceed 54 percent by 2025.

This report titled “China IVD Market, Share, Trends, Regulations, Reimbursement & Key Players Analysis – Forecast to 2025” provides a comprehensive analysis of the China In-Vitro Diagnostics (IVD Market).

This 106 Page report with 34 Figures and 3 Tables has been analyzed from 10 View Points:

1) China IVD Market and Forecast (2009 – 2024)

2) China IVD Market Share and Forecast (2009 – 2024)

3) China IVD Market & Forecast – By Segment (2009 – 2024)

4) Development Environment and Regulatory Status in China IVD market

5) China IVD Market & Forecast – Key Players Sales Analysis (2010 – 2024)

6) Registration for In Vitro Diagnostic Reagents in China

7) Regulatory History/Status/Trends in China IVD Market

8) Reimbursement of IVD Products in China

9) Profiles of Select Private Clinical Labs and Diagnostic Services Companies

10) China IVD Industry Drivers & Challenges

China IVD Market – By Application Segments

1. Clinical Chemistry Market

2. Immunoassay Market

3. Hematology Market

4. Coagulation Market

5. Microbiology Market

6. Molecular Testing Market

7. Self Monitoring of Blood Glucose (SMBG) Market

8. Point of Care Testing (POCT) Market

China IVD Sales & Forecast – Key Players Analysis

1. Roche Diagnostic

2. Abbott Laboratories

3. Sysmex Corporation

4. Mindray Medical International Limited

5. Shanghai Kehua Bio-Engineering Co. Ltd.

6. Others

Profiles of Private Clinical Labs and Diagnostic Services Companies in China

Zhejiang Di’an Diagnostics Technology Co., Ltd

ADICON Clinical Laboratories

Guangzhou Kingmed Diagnostics Center Co. Ltd.

Kindstar Global (Privately held)

BGI-Shenzhen (Privately held)

OriGene Technologies (Privately held)

Data Source

Our employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis research dedicated team of qualified professionals with deep industry experience and expertise.

Research Methodologies

Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.

Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.

Browse our full report with Table of Contents:
http://www.marketreportsonchina.com/marketreports/china-ivd-market-share-trends-regulations-reimbursement-key-players-analysis-forecast-to-2025/1121532

About Market Reports on China:
Market Reports on China is thus the one-stop solution for the entire market research requirements with regards to China.
We provide you with insight and analysis on the country’s economic outlook at the national, regional and city level, presenting deep understanding of disparities and evolutionary paths. Get a complete, consistent and concise view of your markets with comprehensive industry reports. Our latest regional databanks, forecasts, and detailed risk ratings will help you to identify risk and opportunities in every industry and develop strategic plans to deal with the competitiveness in the Chinese market.

Contact us:
Market Reports on China
Tel: +91 22 27810772 / 27810773
Email: info@marketreportsonchina.com
Website: http://www.marketreportsonchina.com

China Simvastatin Market Research Report Forecast to 2023

Market Reports on China Provides the Trending Market Research Report on “Investigation Report on China’s Simvastatin Market, 2019-2023” under Drugs Category. The report offers a collection of superior market research, market analysis, competitive intelligence and Market reports.

The first widely used statin in China is Simvastatin and the only statin that has been included in China’s essential medicine list and needs to complete the consistency evaluation by 2018

Request a free sample copy of Simvastatin Market Report @
http://www.marketreportsonchina.com/marketreports/Sample/Reports/678103

TThe blood lipid levels of Chinese people are rising as China’s economy develops and a high-calorie and high-fat diet becomes increasingly prevalent. In 2018, the overall incidence of dyslipidemia in Chinese adults was up to about 40%. As dyslipidemia is a major cause of coronary heart disease, strokes and other atherosclerotic lesions, the treatment of hyperlipidemia can reduce the incidence of these diseases.

Developed by U.S. company MSD, Simvastatin is a semi-synthetic HMG-CoA reductase inhibitor with Lovastatin as the raw material. It was first launched in 1988, and approved by the FDA in Dec. 1991. The trade name of MSD’s Simvastatin is Zocor. Simvastatin can prevent the development of atherosclerosis and prevent the relapse of heart diseases, and reduce the risks of nonfatal myocardial infarction and myocardial revascularization.

In 1995, MSD introduced Simvastatin to China. Simvastatin is the first widely used statin in China and the only statin that has been included in China’s essential medicine list and needs to complete the consistency evaluation by 2018. And the users of Simvastatin can enjoy some preferential policies. Numerous advertisements and early launch have made Zocor well-known in community-level hospitals. In an agreement with the Chinese government, MSD promised to lower the prices of Simvastatin for a bigger market share.

Our market research shows that the sales value of Simvastatin in sample hospitals in China was about CNY142 million in 2017, and is declining in the competition with other similar drugs. By sales value, China’s Simvastatin market is dominated by Hangzhou MSD Pharmaceutical Co., Ltd., MSD, Guangzhou Nanxin Pharmaceutical Co., Ltd., Cinmed Pharmaceuticals, and Yangtze River Pharmaceutical Group Sichuan Hairong Pharmaceutical Co., Ltd. In 2017, the market share by sales value of Hangzhou MSD Pharmaceutical Co., Ltd. was about 63%, which means that branded Simvastatin still has great advantages on the Chinese market.

According to our estimate, Simvastatin will still have certain growth potential in China from 2019 to 2023 as the incidences of cardiovascular diseases keep increasing with the rising urbanization level, aging population and changing lifestyle.

Topics Covered:
– Development environment of statins in China
– Supply of and demand for Simvastatin in China
– Major Simvastatin manufacturers in China
– Prices of Simvastatin in China
– Prospect of China’s Simvastatin market from 2019 to 2023

Browse our full report with Table of Contents:
http://www.marketreportsonchina.com/marketreports/investigation-report-on-chinas-simvastatin-market-2019-2023/678103

About Market Reports on China:Market Reports on China is thus the one-stop solution for the entire market research requirements with regards to China.
We provide you with insight and analysis on the country’s economic outlook at the national, regional and city level, presenting deep understanding of disparities and evolutionary paths. Get a complete, consistent and concise view of your markets with comprehensive industry reports. Our latest regional databanks, forecasts, and detailed risk ratings will help you to identify risk and opportunities in every industry and develop strategic plans to deal with the competitiveness in the Chinese market.

Contact us:
Market Reports on China
Tel: +91 22 27810772 / 27810773
Email: info@marketreportsonchina.com
Website: http://www.marketreportsonchina.com

Page 1 of 36

Powered by WordPress & Theme by Anders Norén